VivoSeq
Other

Chronic Pelvic Pain

0

Pipeline Programs

6

Active Trials

0

Companies Involved

Chronic Pelvic Pain is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

63/100

Attrition Rate

18/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed5 · 29%
Unknown status3 · 18%
Not yet recruiting3 · 18%
Terminated3 · 18%
Recruiting2 · 12%
Active, not recruiting1 · 6%

Trial Activity

17 trials

Botox for Chronic Pelvic Pain
Recruiting·UUniversity of Miami·Phase 1·NCT06796985·30 enrolled
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
Active, not recruiting··Phase 3·NCT05658874·26 enrolled
Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain
Completed··N/A·NCT02369068·21 enrolled
Effect of Nicotine on Chronic Pelvic Pain
Completed··Phase 4·NCT00440505·20 enrolled
Efficacy of Gralise® for Chronic Pelvic Pain
Terminated··Phase 4·NCT01678911·11 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)